Disclosure statement
No potential conflict of interest was reported by the author(s).
Additional information
Funding
The author(s) reported there is no funding associated with the work featured in this article.
Leukemia & Lymphoma
Volume 64, 2023 - Issue 6
Letters to the Editor
Acalabrutinib is an effective treatment for immune thrombocytopenia associated with chronic lymphocytic leukemia, a case report
David Allsupa Queens Centre for Oncology and Haematology, Castle Hill Hospital, Hull University NHS Trust, Hull, UK;b Centre of Biomedicine, Hull York Medical School, University of Hull, Hull, UKCorrespondence[email protected]
https://orcid.org/0000-0001-6159-6109View further author information
https://orcid.org/0000-0001-6159-6109View further author information & Stefano Molicaa Queens Centre for Oncology and Haematology, Castle Hill Hospital, Hull University NHS Trust, Hull, UKhttps://orcid.org/0000-0003-2795-6507View further author information
https://orcid.org/0000-0003-2795-6507View further author information![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})